Skip to content

Ultrasound-guided cervical nerve root combined with stellate ganglion block in the treatment of patients with herpes zoster neuralgia

Ultrasound-guided cervical nerve root combined with stellate ganglion block in the treatment of patients with herpes zoster neuralgia

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071985
Enrollment
Unknown
Registered
2023-05-31
Start date
2023-04-22
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes zoster

Interventions

Test group:Nerve root+Stellate ganglion block
Control group:Nerve root block

Sponsors

Hefei Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Meeting the diagnostic criteria for HZ with a visual analogue scale (VAS) score of =6 for pain on admission; (2) Herpes zoster accumulated in the unilateral cervical segment (lesions located in the C2-C7 innervation zone); (3) Herpes in the acute phase (herpes within 1 week of appearance) and not systematically treated prior to admission; (4) Age > 50 years; (5) Signed informed consent and not concurrently participating in other clinical trials.

Exclusion criteria

Exclusion criteria: (1) Patients with HZ whose herpes has lasted longer than 1 week or is under treatment; (2) Those with comorbid other skin diseases that cannot be distinguished from HZ; (3) HZ cumulative thoracolumbar segment (lesions located in the T1-L5 nerve distribution area); (4) Patients with hearing impairment and language comprehension disorders; (5) Patients with rheumatic immune system diseases and those currently taking immunosuppressive drugs; (6) Patients with clearly diagnosed neuropsychiatric disorders: e.g. dementia, Parkinson's syndrome, myasthenia gravis, schizophrenia, epilepsy, etc; (7) Refusal to participate in the trial or to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale;

Secondary

MeasureTime frame
Incidence of postherpetic neuralgia;drug dose;ID-pain score;Hospital Anxiety and Depression Scale;Self-Rating Scale of Sleep;

Countries

China

Contacts

Public ContactWang YIwen

Hefei Hospital of Anhui Medical University

17681105722@163.com+86 176 8110 5722

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026